LILLY-H3E-MC-JMEN

Study Sponsor: Lilly

Study Title

A Phase 3, Double-Blind, Placebo-Controlled Study of Maintenance Pemetrexed plus Best Supportive Care versus Best Supportive Care Immediately Following Induction Treatment for Advanced Non-Small Cell Lung Cancer

Medicine or Vaccine (generic name)

Pemetrexed

Sponsor Identification Number

H3E-MC-JMEN

Trial Registry Identification Number(#'s)

NCT00102804

Medical Condition

Non-Small Cell Lung Cancer

Phase

Phase 3

Link to study details on the Lilly Clinical Study Register

Link to study details on ClinicalTrials.gov (if available)

https://clinicaltrials.gov/ct2/show/NCT00102804?term=H3E-MC-JMEN&rank=1

Link to study details on EudraCT (if available)

Not available

Datasets and Documents Available for this Study

Raw dataset	Annotated case report form	Dataset specifications	Protocol with any amendments
Analysis-ready dataset	Reporting and analysis plan	Clinical study report	Ready to Share

Additional information about the data and documents available for this study

Date Added to this Site

June 2015